Company · France
not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts — staff, costs, accreditations — are not available for it.
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Track Les in PolicySpeak: request access →
Work at Les Entreprises du Médicament - LEEM? so we know who speaks for it.
Les Entreprises du Médicament - LEEM filed 2 positions between 6 Jan 2021 and 27 Apr 2021, across 2 of the 583 legislative files tracked here.
The LEEM calls for a robust and agile regulatory framework and incentive system, which encourages advances in science, technology and medicines, draws lessons from COVID-19, and promotes the global competitiveness of industry. Businesses make easier access to medicines for as many patients a real commitment. However, amending legislation is not the only way to address access and affordability issues in Europe.
Filed in French · English published by the European Commission
The LEEM and its 260 members are fully mobilised in the light of the objectives identified in the IIA. Any revision of incentives should be designed to maintain a Europe of innovation (one of the challenges of the Commission’s Pharmaceutical Strategy), but the proposed options do not allow this to be achieved.
Filed in French · English published by the European Commission
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Les Entreprises du Médicament - LEEM next to another organization. Same files, same register facts, side by side. Compare →
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
Showing 5 of 52.
Everything on this page comes from Les Entreprises du Médicament - LEEM’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.